Your browser doesn't support javascript.
loading
Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome.
Kaslow, J E; Rucker, L; Onishi, R.
Afiliación
  • Kaslow JE; Division of Basic and Clinical Immunology, University of California Irvine Medical Center, Orange 92668.
Arch Intern Med ; 149(11): 2501-3, 1989 Nov.
Article en En | MEDLINE | ID: mdl-2684076
Chronic fatigue syndrome is a recently defined entity for which clinical criteria were proposed by the Centers for Disease Control, Atlanta, Ga. A frequently advocated treatment in Southern California is an injectable solution of bovine liver extract containing folic acid and cyanocobalamin (LEFAC). We conducted a double-blind, placebo-controlled, crossover trial of intramuscular LEFAC in 15 patients who met the Centers for Disease Control criteria for chronic fatigue syndrome. Although patients responded to placebo and LEFAC by several criteria of functional status, no significant difference was apparent between response to placebo and that to LEFAC. The placebo response appeared to be strong.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Vitamina B 12 / Síndrome de Fatiga Crónica / Ácido Fólico / Extractos Hepáticos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Intern Med Año: 1989 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Vitamina B 12 / Síndrome de Fatiga Crónica / Ácido Fólico / Extractos Hepáticos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Intern Med Año: 1989 Tipo del documento: Article